Sign inJoin waitlistJoin the waitlist

Yasmin Karimi

Clinical Associate Professor of Internal Medicine · University of Michigan

Credentials: · · · · · ·

History

University of Michigan
Present

Hematology and Medical Oncology
University of Illinois Chicago
2016–2019
Internal Medicine
University of Illinois Chicago
2013–2016
Perelman School of Medicine at the University of Pennsylvania
2009–2013

Research

Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19
New England Journal of Medicine · 2021 · 780 citations
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19
New England Journal of Medicine · 2021 · 743 citations
Epcoritamab in relapsed/refractory large B-cell lymphoma: 2-year follow-up from the pivotal EPCORE NHL-1 trial
Leukemia · 2024 · 130 citations

TP
Tycel Phillips
9 papers
Joshua Brody
6 papers
Julie Vose
6 papers
Stephen Smith
6 papers
Boyu Hu
5 papers
Daniel Landsburg
5 papers
Manali Kamdar
5 papers
Paolo Caimi
5 papers
Sven de Vos
5 papers
Allison Bock
4 papers · 2 as a fellow
AZ
Andrew Zelenetz
4 papers
Elizabeth Budde
4 papers

Clinical trials

Dose De-escalation Study of the PI3k Alpha/Delta Inhibitor, Copanlisib Given in Combination With the Immunotherapeutic Agents, Nivolumab and Rituximab in Patients With Relapsed/Refractory Indolent Lymphoma
Principal investigator · Terminated · Phase 1
University of Michigan Rogel Cancer Center
2020–2023
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2024–2032
Loncastuximab Tesirine in Combination With Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma
Site PI · Recruiting · Phase 2
Juan P. Alderuccio, MD
2022–2030